Yukihiro Hirata
Overview
Explore the profile of Yukihiro Hirata including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
136
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kawahara N, Kobayashi H, Maehana T, Iwai K, Yamada Y, Kawaguchi R, et al.
Diagnostics (Basel)
. 2024 Jun;
14(11).
PMID: 38893596
Background: Endometriosis-associated ovarian cancer (EAOC) is a well-known type of cancer that arises from ovarian endometrioma (OE). OE contains iron-rich fluid in its cysts due to repeated hemorrhages in the...
2.
Yoshida H, Kikuchi A, Tsuda H, Sakamoto A, Fukunaga M, Kaku T, et al.
Hum Pathol
. 2022 Mar;
124:24-35.
PMID: 35339567
Endometrial stromal sarcoma (ESS) is a rare uterine malignancy that requires accurate pathological diagnosis for proper treatment. This study aimed to clarify the discrepancies in the pathological diagnosis of ESS...
3.
Hirata Y, Matsui Y, Wada I, Hosokawa N
Mol Biol Cell
. 2022 Jan;
33(3):ar21.
PMID: 35044867
Collagen is the major protein component of the extracellular matrix. Synthesis of procollagens starts in the endoplasmic reticulum (ER), and three α chains form a rigid triple helix 300-400 nm...
4.
Matsui Y, Hirata Y, Wada I, Hosokawa N
Cell Struct Funct
. 2020 Jun;
45(2):107-119.
PMID: 32554938
Collagen is the most abundant protein in animal tissues and is critical for their proper organization. Nascent procollagens in the endoplasmic reticulum (ER) are considered too large to be loaded...
5.
Narui C, Tanabe H, Shapiro J, Nagayoshi Y, Maruta T, Inoue M, et al.
In Vivo
. 2019 Oct;
33(6):2045-2050.
PMID: 31662536
Background/aim: Hypersensitivity reactions (HSRs) to carboplatin, a key drug for ovarian cancer patients, are problematic. The aim of this study was to evaluate the efficacy and safety of readministration of...
6.
Hirose S, Tanabe H, Nagayoshi Y, Hirata Y, Narui C, Ochiai K, et al.
J Gynecol Oncol
. 2018 Mar;
29(3):e37.
PMID: 29533021
Objective: The aim of the study is to investigate recurrence of stage I epithelial ovarian cancer. Methods: Six hundred two patients diagnosed with stage I epithelial ovarian cancer at 4...
7.
Yanaihara N, Hirata Y, Yamaguchi N, Noguchi Y, Saito M, Nagata C, et al.
Mol Carcinog
. 2015 Apr;
55(5):832-41.
PMID: 25856562
Among epithelial ovarian cancers, clear cell carcinoma of the ovary (CCC) has unique clinical and molecular characteristics that include chemoresistance resulting in poor prognosis. It was shown that CCC recently...
8.
Okamoto A, Sehouli J, Yanaihara N, Hirata Y, Braicu I, Kim B, et al.
PLoS One
. 2015 Feb;
10(2):e0116977.
PMID: 25658832
When compared with other epithelial ovarian cancers, the clinical characteristics of ovarian clear cell adenocarcinoma (CCC) include 1) a higher incidence among Japanese, 2) an association with endometriosis, 3) poor...
9.
Hirata Y, Murai N, Yanaihara N, Saito M, Saito M, Urashima M, et al.
BMC Cancer
. 2014 Nov;
14:799.
PMID: 25366985
Background: Epithelial ovarian cancer (EOC) is the most common cause of gynecological malignancy-related mortality. Ovarian clear cell carcinoma (CCC) has unique clinical characteristics and behaviors that differ from other histological...
10.
Yanaihara N, Anglesio M, Ochiai K, Hirata Y, Saito M, Nagata C, et al.
Int J Oncol
. 2012 Jul;
41(3):1094-100.
PMID: 22751940
Cytokine expression in a tumor microenvironment can impact both host defense against the tumor and tumor cell survival. In this study, we sought to clarify whether the cytokine gene expression...